Lack of association between clinical signs and laboratory parameters in dogs with hyperadrenocorticism before and during trilos
![DE60220400T9 - USE OF 2-ALPHA-CYANO-4-ALPHA, 5-ALPHA-EPOXYANDROSTAN-17-BETA-OL-3-ON DERIVATIVES FOR LOWERING THE CORTISOL SERUM MIRROR AND TREATING ASSOCIATED DISEASES - Google Patents DE60220400T9 - USE OF 2-ALPHA-CYANO-4-ALPHA, 5-ALPHA-EPOXYANDROSTAN-17-BETA-OL-3-ON DERIVATIVES FOR LOWERING THE CORTISOL SERUM MIRROR AND TREATING ASSOCIATED DISEASES - Google Patents](https://patentimages.storage.googleapis.com/51/ca/4c/21e3b256e05b6b/00280001.png)
DE60220400T9 - USE OF 2-ALPHA-CYANO-4-ALPHA, 5-ALPHA-EPOXYANDROSTAN-17-BETA-OL-3-ON DERIVATIVES FOR LOWERING THE CORTISOL SERUM MIRROR AND TREATING ASSOCIATED DISEASES - Google Patents
Comparison of two treatment regimens with trilostane in dogs with pituitary-dependent hyperadrenocorticism
![Trilostan : Vetoryl 30 mg, 60 mg ja 120 mg kapsel för hund, Arnolds Veterinary Products Ltd, Britannien Trilostan : Vetoryl 30 mg, 60 mg ja 120 mg kapsel för hund, Arnolds Veterinary Products Ltd, Britannien](http://www.julkari.fi//bitstream/handle/10024/121348/tabu22007_ruo.pdf.jpg?sequence=3&isAllowed=y)